ANRS, Emerging Infectious Diseases
4 clinical trials · 4 recruiting · OTHER_GOV
Trials by ANRS, Emerging Infectious Diseases
RECRUITINGNCT05655702
DRug Use & Infections in ViEtnam: TuBerculosis Control
The overarching purpose of the proposed research is to demonstrate that a targeted, multi-component community-based intervention among PWID in Hai Phong will decrease TB...
Sponsor: ANRS, Emerging Infectious DiseasesEnrolling: 40002 locations
Tuberculosis
RECRUITINGPhase 2NCT05590455
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
Randomized phase II clinical trial which aims to assess the impact on 3-month mortality and safety of adding adalimumab to standard treatment (anti-tuberculosis drugs and...
Sponsor: ANRS, Emerging Infectious DiseasesEnrolling: 1303 locations
Tuberculous MeningitisHIV I Infection
RECRUITINGNCT04166266
National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
This is a multicentre observational study with prospective and retrospective data collection and retrospective data collection and biological collection from patients with HBV/HDV...
Sponsor: ANRS, Emerging Infectious DiseasesEnrolling: 80020 locations
Hepatitis D, ChronicHepatitis B, Chronic
RECRUITINGPhase 1 / Phase 2NCT07113106
Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult Healthy Volunteers
The clinical trial is a phase1/2a, open-label, dose-escalating, multicentre trial evaluating the safety and immunogenicity of the CD40.Pan.CoV vaccine, adjuvanted or not, as a...
Sponsor: ANRS, Emerging Infectious DiseasesEnrolling: 487 locations
Healthy Volunteers